CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

SOPHiA GENETICS Reports Second Quarter 2026 Results

EarningsNeutral
AI Analysis

Summary

SOPHiA GENETICS reported Q2 2026 financial results with revenue of $23.3 million, representing growth compared to prior periods. The company is a global leader in AI-driven precision medicine.

Financial Highlights

Revenue

$23.3 million

Importance:2/10
Sentiment:
0.00
earningsQ2 2026revenue growthAI-driven precision medicine
Related Companies

Read the original article

Published by PR Newswire Biotech on August 4, 2026 10:45 AM

Read Original